TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE
6.1. Overview
6.2. Allogeneic
6.3. Autologous
7. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION
7.1. Overview
7.2. Acute Myeloid Leukemia
7.3. Acute Lymphoblastic Leukemia
7.4. Hodgkin Lymphoma
7.5. Non-Hodgkin Lymphoma
7.6. Multiple Myeloma
7.7. Other Non-Malignant Disorders
8. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION
8.1. Overview
8.2. Bone Marrow Transplant
8.3. Peripheral Blood Stem Cells Transplant
8.4. Cord Blood Transplant
9. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Hematopoietic Stem Cell Transplantation Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Hematopoietic Stem Cell Transplantation Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023
11. COMPANY PROFILES
11.1. Pluristem Therapeutics Inc
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. CellGenix GmbH
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Regen Biopharma Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Lonza Group
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. SANOFI
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Taiga Biotechnologies, Inc
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Takeda Pharmaceutical Company Limited
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Escape Therapeutics, Inc
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. BLUEBIRD BIO
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Talaris Therapeutics
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 US: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 10 US: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 11 US: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 CANADA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 13 CANADA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 14 CANADA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 EUROPE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 16 EUROPE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 17 EUROPE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 GERMANY: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 19 GERMANY: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 20 GERMANY: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 21 FRANCE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 22 FRANCE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 23 FRANCE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 ITALY: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 25 ITALY: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 26 ITALY: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 27 SPAIN: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 28 SPAIN: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 29 SPAIN: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 30 UK: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 31 UK: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 32 UK: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 REST OF EUROPE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 34 REST OF EUROPE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 35 REST OF EUROPE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 36 ASIA-PACIFIC: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 37 ASIA-PACIFIC: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 38 ASIA-PACIFIC: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 39 JAPAN: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 40 JAPAN: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 41 JAPAN: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 42 CHINA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 43 CHINA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 44 CHINA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 INDIA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 46 INDIA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 47 INDIA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 48 AUSTRALIA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 49 AUSTRALIA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 50 AUSTRALIA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 53 SOUTH KOREA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 60 MIDDLE EAST: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 63 AFRICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 64 AFRICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 65 AFRICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 66 LATIN AMERICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE, 2019-2032 (USD BILLION)
TABLE 67 LATIN AMERICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 68 LATIN AMERICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET
FIGURE 4 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, SHARE (%), BY TRANSPLANT TYPE, 2023
FIGURE 5 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, SHARE (%), BY INDICATION, 2023
FIGURE 6 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 7 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 PLURISTEM THERAPEUTICS INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 PLURISTEM THERAPEUTICS INC: SWOT ANALYSIS
FIGURE 15 CELLGENIX GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 CELLGENIX GMBH: SWOT ANALYSIS
FIGURE 17 REGEN BIOPHARMA INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 REGEN BIOPHARMA INC: SWOT ANALYSIS
FIGURE 19 LONZA GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 LONZA GROUP: SWOT ANALYSIS
FIGURE 21 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 SANOFI: SWOT ANALYSIS
FIGURE 23 TAIGA BIOTECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 TAIGA BIOTECHNOLOGIES, INC.: SWOT ANALYSIS
FIGURE 25 TAKEDA PHARMACEUTICAL COMPANY LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 TAKEDA PHARMACEUTICAL COMPANY LIMITED: SWOT ANALYSIS
FIGURE 27 ESCAPE THERAPEUTICS, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 ESCAPE THERAPEUTICS, INC: SWOT ANALYSIS
FIGURE 29 BLUEBIRD BIO: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 BLUEBIRD BIO: SWOT ANALYSIS
FIGURE 31 TALARIS THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 TALARIS THERAPEUTICS: SWOT ANALYSIS
